Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways (Q28679171)

ChEBI release 2020-05-28

1 reference

1 reference

ChEBI release 2020-05-28

R. Bort

1

1 reference

6 February 2017

K. Macé

2

1 reference

6 February 2017

A. Boobis

3

1 reference

6 February 2017

M. J. Gómez-Lechón

4

1 reference

6 February 2017

A. Pfeifer

5

1 reference

6 February 2017

J. Castell

Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis

6

1 reference

6 February 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

6 February 2017

Biochemical Pharmacology

1 reference

6 February 2017

58

1 reference

6 February 2017

5

1 reference

6 February 2017

787–796

1 reference

6 February 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

A new metabolite of diclofenac sodium in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Diclofenac-associated hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Reversible hepatitis associated with diclofenac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Diclofenac associated hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Immunochemical detection of protein adducts in cultured human hepatocytes exposed to diclofenac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Interindividual variability in catalytic activity and immunoreactivity of three major human liver cytochrome P450 isozymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

High Expression of Human CYP2C in Immortalized Human Liver Epithelial Cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7

Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900167-7